Bansisons Tea Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/03/2026 ,inter alia, to consider and approve Independent Directors Meeting
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The company has informed BSE that a separate meeting of its Independent Directors will be held on Friday, 20 March 2026 at its registered office in Surat. The agenda is routine and regulatory in nature: review the performance of Non-Independent Directors and the Board as a whole, review the performance of the Chairperson, and assess the quality, quantity and timeliness of information flow to the Board. No financial results, dividend, fundraising, or major corporate action is being considered in this meeting. The filing is signed by Director Anilkumar Mohanbhai Amreliya (DIN: 11339148). The company also appears to have undergone a name change from Bansisons Tea Industries Limited to Novyra Pharmachem Limited, suggesting a shift in business identity.
This is a routine SEBI-mandated compliance filing and is unlikely to have any direct impact on the stock price or shareholder value. However, the rebranding from Bansisons Tea Industries to Novyra Pharmachem may indicate a strategic pivot in the company's business focus, which investors should track.